Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MPI | P34949 | 1/20 | 0.31 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.31 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.30 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10300813 | 1.00 | L3MBTL1 (0.33) | L3MBTL1ALDH1A1MAPTMPISSTR3 | |
| SCHEMBL10300871 | 1.00 | L3MBTL1 (0.33) | L3MBTL1ALDH1A1MAPTMPISSTR3 | |
| SCHEMBL10300809 | 1.00 | L3MBTL1 (0.33) | L3MBTL1ALDH1A1MAPTMPISSTR3 | |
| SCHEMBL10040974 | 1.00 | L3MBTL1 (0.33) | L3MBTL1ALDH1A1MAPTMPISSTR3 | |
| SCHEMBL14765562 | 0.89 | ANPEP (0.31) | ALDH1A1MAPTMPI | |
| SCHEMBL13929516 | 0.89 | ANPEP (0.31) | ALDH1A1MAPTMPI | |
| SCHEMBL13951685 | 0.89 | ANPEP (0.31) | ALDH1A1MAPTMPI | |
| SCHEMBL10040968 | 0.86 | L3MBTL1 (0.44) | L3MBTL1ALDH1A1MAPTMPI | |
| SCHEMBL10040967 | 0.86 | L3MBTL1 (0.44) | L3MBTL1ALDH1A1MAPTMPI | |
| SCHEMBL14765555 | 0.85 | MAPT (0.37) | L3MBTL1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8410295-B2 | Method for production of optically active epoxy compound, and complex used therefor and process for producing the same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-04-02 | — | — | US | disclosed |
| US-8410295-B2 | Method for production of optically active epoxy compound, and complex used therefor and process for producing the same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-04-02 | — | — | US | disclosed |
| US-8394974-B2 | Process for producing optically active chromene oxide compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-03-12 | — | — | US | disclosed |
| US-20120178954-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE EPOXY COMPOUND, AND COMPLEX USED THEREFOR AND PROCESS FOR PRODUCING THE SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120178954-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE EPOXY COMPOUND, AND COMPLEX USED THEREFOR AND PROCESS FOR PRODUCING THE SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-07-12 | — | — | US | disclosed |
| US-8163941-B2 | Reacting an unsaturated compound with oxidier in presence of a oxidation catalyst | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-04-24 | — | — | US | disclosed |
| US-8163941-B2 | Reacting an unsaturated compound with oxidier in presence of a oxidation catalyst | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20080071099-A1 | Method for Production of Optically Active Epoxy Compound, and Complex Used Therefor and Process for Producing the Same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-03-20 | — | — | US | disclosed |
| US-20080071099-A1 | Method for Production of Optically Active Epoxy Compound, and Complex Used Therefor and Process for Producing the Same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080071099-A1 | Method for Production of Optically Active Epoxy Compound, and Complex Used Therefor and Process for Producing the Same | EPRS1, PPOX, POR | L3MBTL1 3054/4885ALDH1A1 840/4885MAPT 4881/4885 |
| US-20120178954-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE EPOXY COMPOUND, AND COMPLEX USED THEREFOR AND PROCESS FOR PRODUCING THE SAME | CYP4F11, CYP51A1, COASY | L3MBTL1 3098/4885ALDH1A1 2091/4885MAPT 4823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.